Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGE ANAEMIA
2024-515920-35-01Phase 4Authorised
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Aug 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in iron deficiency anemia (IDA) comparing Monofer with Placebo (2 arms). Primary endpoint: World Health Organization Disability Assessment Schedule 2.0 (WHODAS-12) score at POD 90. Planned start Aug 2024; status: authorised.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2024-515920-35-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515920-35-01.